These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30198358)

  • 21. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa.
    Ntshanga SP; Rustomjee R; Mabaso ML
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):571-4. PubMed ID: 19394664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of tuberculosis and HIV co-infection in Cotonou, Benin.
    Agodokpessi G; Ade G; Ade S; Wachinou AP; Affolabi D; Anagonou S; Gninafon M
    Med Mal Infect; 2012 Nov; 42(11):561-6. PubMed ID: 23044083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis.
    Roscoe C; Lockhart C; de Klerk M; Baughman A; Agolory S; Gawanab M; Menzies H; Jonas A; Salomo N; Taffa N; Lowrance D; Robsky K; Tollefson D; Pevzner E; Hamunime N; Mavhunga F; Mungunda H
    BMC Public Health; 2020 Dec; 20(1):1838. PubMed ID: 33261569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan.
    Wang JY; Sun HY; Wang JT; Hung CC; Yu MC; Lee CH; Lee LN
    PLoS One; 2015; 10(12):e0144136. PubMed ID: 26633835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Mbatchou Ngahane BH; Dahirou F; Tchieche C; Wandji A; Ngnié C; Nana-Metchedjin A; Nyankiyé E; Endale Mangamba ML; Kuaban C
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1609-1614. PubMed ID: 28000583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.
    Ahmad T; ; Khan M; Khan MM; Ejeta E; Karami M; Ohia C
    Int J Mycobacteriol; 2017; 6(4):360-364. PubMed ID: 29171450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation.
    Balabanova Y; Drobniewski F; Fedorin I; Zakharova S; Nikolayevskyy V; Atun R; Coker R
    Respir Res; 2006 Mar; 7(1):44. PubMed ID: 16556324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia.
    Zenebe Y; Adem Y; Mekonnen D; Derbie A; Bereded F; Bantie M; Tulu B; Hailu D; Biadglegne F
    BMC Public Health; 2016 Aug; 16():688. PubMed ID: 27485507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis treatment outcomes and interruption among patients assessing DOTS regimen in a tertiary hospital in semi-urban area of south-western Nigeria.
    Omotosho BA; Adebayo AM; Adeniyi BO; Ayodeji OO; Ilesanmi OS; Kareem AO; Akitikori OT; Erhabor GE
    Niger J Med; 2014; 23(1):51-6. PubMed ID: 24946455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
    Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of alternate day Directly Observed Treatment Short-course (DOTS) in skeletal tuberculosis - A retrospective study.
    Chopra R; Bhatt R; Biswas SK; Bhalla R
    Indian J Tuberc; 2018 Jan; 65(1):70-75. PubMed ID: 29332653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study.
    Ali SA; Mavundla TR; Fantu R; Awoke T
    BMC Infect Dis; 2016 Nov; 16(1):640. PubMed ID: 27814693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    Eshetie S; Gizachew M; Alebel A; van Soolingen D
    PLoS One; 2018; 13(3):e0194675. PubMed ID: 29554144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.